Fig. 1From: Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory frameworkComparison of the characterisation of drug substances and drug products in conventional (“classic”) medicines (left) versus in radiopharmaceuticals, where the drug substance cannot be isolated (right)Back to article page